M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-08
DOI
10.1186/s13045-019-0839-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8
- (2019) Shi Chen et al. CANCER LETTERS
- The Critical Role of RNA m6A Methylation in Cancer
- (2019) Qing Lan et al. CANCER RESEARCH
- MiR-3619-5p hampers proliferation and cisplatin resistance in cutaneous squamous-cell carcinoma via KPNA4
- (2019) Mingfeng Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans
- (2019) Li Che et al. GUT
- m6A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1
- (2019) Yingmin Wu et al. Molecular Cancer
- Long non-coding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to sponge miR-590-3p/miR-1275 and upregulate ITGB3
- (2019) Zi-Qi Zheng et al. CANCER RESEARCH
- A Noncoding Regulatory RNAs Network Driven by Circ‐CDYL Acts Specifically in the Early Stages Hepatocellular Carcinoma
- (2019) Yanping Wei et al. HEPATOLOGY
- Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA‐5095 in cervical cancer
- (2019) Hui Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Nanotechnology-based siRNA delivery strategies for metastatic colorectal cancer therapy
- (2019) Ana Rita Sousa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- circHECTD1 facilitates glutaminolysis to promote gastric cancer progression by targeting miR-1256 and activating β-catenin/c-Myc signaling
- (2019) Juan Cai et al. Cell Death & Disease
- Preclinical models for precision oncology
- (2018) Maider Ibarrola-Villava et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Functional Classification and Experimental Dissection of Long Noncoding RNAs
- (2018) Florian Kopp et al. CELL
- Long Noncoding RNA LINC00958 Accelerates Gliomagenesis Through Regulating miR-203/CDK2
- (2018) Erkun Guo et al. DNA AND CELL BIOLOGY
- RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2
- (2018) Mengnuo Chen et al. HEPATOLOGY
- Multiple functions of m6A RNA methylation in cancer
- (2018) Yutian Pan et al. Journal of Hematology & Oncology
- Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation
- (2018) Xirui Liu et al. Molecular Cancer
- Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma
- (2018) Xuejie Min et al. Molecular Oncology
- Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
- (2018) Chun-Ming Wong et al. Nature Reviews Gastroenterology & Hepatology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A new look at molecular biology of breast cancer
- (2018) Chi Ma et al. CANCER BIOLOGY & THERAPY
- Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
- (2018) James S.V. Lally et al. Cell Metabolism
- Emerging roles of long non-coding RNAs in tumor metabolism
- (2018) Hui Sun et al. Journal of Hematology & Oncology
- MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21
- (2018) Qingsong Zhang et al. Cell Death & Disease
- CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619–5p/CTNNB1 axis and activating Wnt/β-catenin pathway
- (2018) Aichun Tan et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Acknowledgement to our reviewers
- (2018) JOURNAL OF HEPATOLOGY
- Transcriptome landscape of long intergenic non-coding RNAs in endometrial cancer
- (2017) Bei Jun Chen et al. GYNECOLOGIC ONCOLOGY
- A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
- (2017) Wen Ni et al. Journal of Hematology & Oncology
- The generation of compartmentalized nanoparticles containing siRNA and cisplatin using a multi-needle electrohydrodynamic strategy
- (2017) Maria F. Pina et al. Nanoscale
- m6AVar: a database of functional variants involved in m6A modification
- (2017) Yueyuan Zheng et al. NUCLEIC ACIDS RESEARCH
- Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival
- (2017) Marin E. Nelson et al. Nature Communications
- Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer
- (2017) Anna Katharina Seitz et al. Scientific Reports
- Gemcitabine and Antisense-microRNA Co-encapsulated PLGA–PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy
- (2016) Rammohan Devulapally et al. ACS Applied Materials & Interfaces
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
- (2016) Peter L. Turecek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression
- (2016) Senmao Li et al. ONCOLOGY REPORTS
- Long Noncoding RNA HULC Modulates Abnormal Lipid Metabolism in Hepatoma Cells through an miR-9-Mediated RXRA Signaling Pathway
- (2015) M. Cui et al. CANCER RESEARCH
- Role of MiR-3619-5p in β-Catenin-Mediated Non-Small Cell Lung Cancer Growth and Invasion
- (2015) Xuecai Niu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma
- (2015) Hirayuki Enomoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
- (2014) Charlene M. Dawidczyk et al. JOURNAL OF CONTROLLED RELEASE
- Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles
- (2013) Qin Liu et al. BIOMATERIALS
- Nanoparticle PEGylation for imaging and therapy
- (2011) Jesse V Jokerst et al. Nanomedicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started